Astrana Health, Inc. (ASTH)
- Previous Close
36.56 - Open
36.59 - Bid 36.65 x 200
- Ask 36.75 x 100
- Day's Range
36.59 - 37.36 - 52 Week Range
28.87 - 45.71 - Volume
82,856 - Avg. Volume
157,857 - Market Cap (intraday)
1.669B - Beta (5Y Monthly) 1.09
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 6, 2024 - May 10, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
51.05
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
www.astranahealth.com1,800
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ASTH
Performance Overview: ASTH
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ASTH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ASTH
Valuation Measures
Market Cap
1.67B
Enterprise Value
1.69B
Trailing P/E
28.47
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.24
Price/Book (mrq)
2.72
Enterprise Value/Revenue
1.22
Enterprise Value/EBITDA
13.69
Financial Highlights
Profitability and Income Statement
Profit Margin
4.38%
Return on Assets (ttm)
5.57%
Return on Equity (ttm)
11.94%
Revenue (ttm)
1.39B
Net Income Avi to Common (ttm)
60.72M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
296.3M
Total Debt/Equity (mrq)
78.15%
Levered Free Cash Flow (ttm)
74.56M
Research Analysis: ASTH
Company Insights: ASTH
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: ASTH
ASTH: Lowering target price to $39.00
ASTRANA HEALTH INC has an Investment Rating of HOLD; a target price of $39.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetASTH: Lowering target price to $40.00
ASTRANA HEALTH INC has an Investment Rating of HOLD; a target price of $40.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetASTH: Raising target price to $45.00
ASTRANA HEALTH INC has an Investment Rating of HOLD; a target price of $45.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetASTH: Raising target price to $44.00
ASTRANA HEALTH INC has an Investment Rating of HOLD; a target price of $44.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target